openPR Logo
Press release

Pneumococcal Vaccines Market Set to Witness Significant Growth by 2025-2032 | Pfizer Inc.,Merck & Co., Inc., GlaxoSmithKline plc (GSK)

08-19-2025 12:15 PM CET | Health & Medicine

Press release from: Coherent Market Insights Pvt. Ltd.

Pneumococcal Vaccines Market

Pneumococcal Vaccines Market

Pneumococcal Vaccines Market is estimated to be valued at USD 9.38 Bn in 2025 and is expected to reach USD 13.29 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.

The Pneumococcal Vaccines Market Research Report results from rigorous investigation and analysis carried out by our seasoned market research experts. It delivers a comprehensive view of the Pneumococcal Vaccines Market between 2025 and 2032, covering competitive dynamics, consumer behavior patterns, and technological breakthroughs. Industry participants will find this report highly valuable-equipping them with actionable intelligence to make strategic decisions and maintain an edge in a fast-changing market environment. Featuring an exhaustive table of contents, clear figures, tables, and charts, the report presents deeper understanding across key factors. The Pneumococcal Vaccines Market Size has steadily expanded, fueled by rising demand, a growing customer base, and continuous innovations. Our report dissects all these elements, offering insight into market trends, drivers and challenges, competitive dynamics, and forward-looking growth opportunities in the Pneumococcal Vaccines sector.

Request a Sample of the Pneumococcal Vaccines Analysis Report! https://www.coherentmarketinsights.com/insight/request-sample/2295

🎯 Scope of Pneumococcal Vaccines Market Report:

Our Pneumococcal Vaccines Market Research delivers in-depth analysis of industry trends, key growth drivers, and notable challenges. It includes refined segmentation by product type, application, and geography. The report pinpoints leading companies and their strategic postures and spotlights emerging growth areas. We explore consumer preferences, forecast market size and trajectory, and assess the regulatory and technological forces shaping the future of the Pneumococcal Vaccines market.

Key Players Highlighted in This Report:

• Pfizer Inc.,Merck & Co. Inc.
• GlaxoSmithKline plc (GSK)
• Sanofi
• CSL Limited
• Serum Institute of India Pvt. Ltd.
• Vaxcyte Inc.
• Astellas Pharma Inc.
• Panacea Biotec Ltd.
• Walvax Biotechnology Co., Ltd.,
• Beijing Minhai Biotechnology Co., Ltd.,
• Merck KGaA
• Takeda Pharmaceutical Company Limited
• AbbVie Inc.
• Novartis AG
• Johnson & Johnson
• Biovac
• Bharat Biotech
• Inovio Pharmaceuticals Inc.
• Hilleman Laboratories Pvt. Ltd

Comprehensive Segmentation in this Report:

• By Vaccine Type:Pneumococcal Conjugate Vaccines (PCVs) (PCV13 (Prevnar 13/Prevenar 13), PCV10 (Synflorix), PCV7 (Prevnar/Prevenar)) and Pneumococcal Polysaccharide Vaccines (PPVs) (PPSV23 (Pneumovax 23), PPSV14 (Pneumo 14))
• By Target Population:Adults (≥ 65 years), Children (< 5 years), High-Risk Adults (18-64 years)
• By Route of Administration:Intramuscular , Subcutaneous
• By Distribution Channel:Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

By Regions and Countries

◘ North America (U.S., Canada, Mexico)
◘ Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
◘ Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
◘ South America (Brazil, Argentina, Rest of SA)
◘ Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

Request a Sample Copy! https://www.coherentmarketinsights.com/insight/request-sample/2295

Comprehensive Insights of the Pneumococcal Vaccines Market Report (2025-2032)
✦ Thorough market analysis covering size, trends, forecasts, and segmentation (2025-2032).
✦ Competitive landscape with key players, benchmarking, positioning, and strategic approaches.
✦ Regional breakdown with revenue mapping and country-specific variations.
✦ Identification of drivers, constraints, opportunities, and emerging market trends.
✦ Strategic insights via Porter's Five Forces for well-informed decision-making.
✦ Future outlook incorporating global and regional trends with growth strategies.

Reasons to Purchase the Report

👉 Strategic Competitor Insights: Receive targeted intelligence on key competitors to refine your sales and marketing playbook.
👉 Track Emerging Players: Pinpoint newcomers with promising product lines and craft responsive strategies.
👉 Target Client Identification: Identify potential partner segments for better market alignment.
👉 Tactical Initiative Development: Learn where market leaders are focusing to shape your own actionable plans.
👉 M&A Planning: Identify top manufacturers to guide strategic mergers or acquisitions.
👉 Licensing Strategy Support: Discover licensing opportunities to expand your business footprint.
👉 Presentation Readiness: Leverage reliable data and insights to elevate your internal or external presentations. Our research combines secondary data, primary interviews with industry professionals and competitors, and validation through the Coherent Market Insights regional database. Experts across regions have vetted both qualitative and quantitative findings using insights from value-chain participants.

Table of Contents: Market Scenario 2025 - Pneumococcal Vaccines

Chapter 1: Introduction - Market Drivers, Product Objectives, and Research Scope of the Pneumococcal Vaccines Industry
Chapter 2: Executive Summary - Overview of the Pneumococcal Vaccines Market
Chapter 3: Market Dynamics - Key Drivers, Trends, Challenges, and Opportunities
Chapter 4: Market Factor Analysis - Supply/Value Chain, PESTEL, Market Entry, Patents & Trademarks
Chapter 5: Segmentation by Type, End-User, and Region/Country (2025-2032)
Chapter 6: Leading Manufacturers - Competitive Landscape, Peer Benchmarking, Company Profiles
Chapter 7: Market Evaluation by Segments, Countries, and Manufacturers - Revenue & Sales Share (2025-2032)
Chapters 8 & 9: Appendix - Methodology and Data Sources

Get Up to 25% Discount on the Pneumococcal Vaccines Analysis Report! https://www.coherentmarketinsights.com/insight/buy-now/2295

FAQ's

Q.1 What are the main factors influencing the Pneumococcal Vaccines industry?
Q.2 Which companies are leading in this space?
Q.3 What are the market's opportunities, risks, and structure?
Q.4 Which top firms show differences in sales, revenue, and pricing across markets?
Q.5 How are market types and applications, deals, revenue, and value explored?
Q.6 How does the market assess agreements, income, and value within a business domain?

Author of this Marketing PR:

Alice Mutum is a highly experienced Senior Content Editor at Coherent Market Insights with seven years in content strategy and development. She expertly applies SEO best practices and modern digital marketing tactics to craft compelling, high-ranking content. As an editor, Alice ensures every report is grammatically flawless, data-accurate, and precisely tailored to reader needs-earning her reputation for excellence in market intelligence.

📞 Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: + 12524771362
U.K.: + 442039578553
AUS: + 61879247805
INDIA: +91-848-285-0837

About CMI:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumococcal Vaccines Market Set to Witness Significant Growth by 2025-2032 | Pfizer Inc.,Merck & Co., Inc., GlaxoSmithKline plc (GSK) here

News-ID: 4149667 • Views:

More Releases from Coherent Market Insights Pvt. Ltd.

Digital Twin Market Outlook (2025-2032) : Strategic Growth Insights, Revenue Trends and Innovation Amidst Leaders Like General Electric, IBM Corporation, PTC
Digital Twin Market Outlook (2025-2032) : Strategic Growth Insights, Revenue Tre …
Coherent Market Insights Reports has released a detailed research analysis on the Global "Digital Twin Market" 2025, highlighting key trends, growth dynamics, and forecast insights through 2032. This comprehensive report presents an in-depth evaluation of the market landscape, analyzing the factors that influence industry growth, including manufacturers, suppliers, market participants, and end users. It offers valuable insights into the core drivers fueling market expansion across various segments such as product
How the Genomics Market Will Evolve by 2032 - Growth Drivers, Segments, and Revenue Trends | Thermo Fisher Scientific, Inc., Agilent Technologies
How the Genomics Market Will Evolve by 2032 - Growth Drivers, Segments, and Reve …
The Genomics Market : A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Genomics Market dynamics. The report includes Porter's Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons to understand a valuable resource. Also, the report spans the
Ferro Manganese Market Evolution by 2032 - Disruptive Innovations, Regional Insights, and Growth Opportunities | Monnet Group, Maithan Alloys Limited
Ferro Manganese Market Evolution by 2032 - Disruptive Innovations, Regional Insi …
Coherent Market Insights has added a new research study on the Global "Ferro Manganese Market" 2025 by Size, Growth, Trends, and Dynamics, Forecast to 2032 which is a result of an extensive examination of the market patterns. This report covers a comprehensive investigation of the information that influences the market regarding fabricates, business providers, market players, and clients. The report provides data about the aspects which drive the expansion of
Xerostomia Therapeutics Market Exclusive Report with Detailed Study Analysis By 2025-2032 | Eisai Inc., Hikma Pharmaceuticals, Synedgen
Xerostomia Therapeutics Market Exclusive Report with Detailed Study Analysis By …
Overview The "Xerostomia Therapeutics Market 2025 Forecast to 2032" report delivers precise global, regional, and country-level insights backed by reliable economic analysis. It presents a clear view of the competitive environment and includes a detailed supply chain study to help businesses anticipate shifts in industry practices. The study also assesses the present market scenario of the Xerostomia Therapeutics industry and outlines future growth prospects, technological developments, investment opportunities, and financial outlook.

All 5 Releases


More Releases for Pneumo

Hemangioma Market Strategic Study Sharing Spotlight in Global Industry |Key Comp …
A Broad Analysis of the "Worldwide Hemangioma market “methodology of the leading organizations in the exactness of import/export utilization, industry activity figures, cost, value, revenue and gross edges. Hemangioma Market – Definition The hemangioma market is growing mainly due to the rising cases of hemangioma. According to a recent study report published by the Market Research Future, The hemangioma market is booming and expected to gain prominence over the forecast period. The market
Spirometers Market Size Projected to Rise Lucratively during 2021
Spirometer is a medical device designed to measure the air capacity of the lungs by measuring the volume of air inhaled and exhaled by the organs. Spirometers generate pneuma- tachograph, which helps to measure lung performance in order to diagnose and monitor patients’ respiratory disorders. A spirometer is used for the diagnosis of asthma, chronic obstructive diseases, tuberculosis, cystic fibrosis, silicosis, black lung, and other respiratory diseases.
Technology Spending on Revenue Hemangioma Market 2018 | Leading Market Players A …
This Market report “Global Hemangioma Market Research Report 2018”provides detailed insight covering all important parameters including Development Trends, Challenges, Opportunities, Key Manufacturers and Competitive Analysis. Hemangioma Market – Definition The hemangioma market is growing mainly due to the rising cases of hemangioma. According to a recent study report published by the Market Research Future, The hemangioma market is booming and expected to gain prominence over the forecast period. The market is forecasted to
Technology Spending on Revenue Hemangioma Market 2018 | Leading Market Players A …
Market Research Future recently presented Global Hemangioma Market study with detailed review, portraying about the Product/Industry Scope and expounds market outlook and status to 2023. Hemangioma Market – Definition The hemangioma market is growing mainly due to the rising cases of hemangioma. According to a recent study report published by the Market Research Future, The hemangioma market is booming and expected to gain prominence over the forecast period. The market is forecasted to
Spirometers Market Expected Size, Status and Forecast by 2015 to 2021: Persisten …
Spirometer is a medical device designed to measure the air capacity of the lungs by measuring the volume of air inhaled and exhaled by the organs. Spirometers generate pneuma- tachograph, which helps to measure lung performance in order to diagnose and monitor patients’ respiratory disorders. A spirometer is used for the diagnosis of asthma, chronic obstructive diseases, tuberculosis, cystic fibrosis, silicosis, black lung, and other respiratory diseases.
Global Spirometers Market to Witness Comprehensive Growth by 2021
Spirometer is a medical device designed to measure the air capacity of the lungs by measuring the volume of air inhaled and exhaled by the organs. Spirometers generate pneuma- tachograph, which helps to measure lung performance in order to diagnose and monitor patients’ respiratory disorders. A spirometer is used for the diagnosis of asthma, chronic obstructive diseases, tuberculosis, cystic fibrosis, silicosis, black lung, and other respiratory diseases. Spirometers are used